Clinicians' viewpoints on current paradigms of care and research in Parkinson's disease

Area of Science:

• Neurology
• Clinical Trials
• Pharmacoeconomics

Background:

• Translational research in Parkinson's disease (PD) shows a gap between promising preclinical findings and clinical trial outcomes.
• Novel PD drugs with improved pharmacokinetics face limited clinical adoption post-approval.

Purpose of the Study:

• To review current Parkinson's disease research initiatives from a clinical perspective.
• To identify barriers hindering the translation of research into clinical practice and drug utilization.

Main Methods:

• Literature review of recent PD research and clinical trial data.
• Analysis of factors affecting drug accessibility and clinician prescribing habits.

Main Results:

• Repeated failures in clinical trials highlight a disconnect between experimental success and patient outcomes.
• Global disparities in drug availability and financial constraints limit the use of new PD medications.
• Uncertainty in pharmaceutical return on investment may decrease interest in novel PD treatment research.

Conclusions:

• Clinicians critically evaluate treatment claims amidst challenges in research translation and drug implementation.
• Addressing access and economic hurdles is crucial for advancing Parkinson's disease patient care and research.
• The current landscape may impede the development of new therapies for motor and non-motor symptoms in Parkinson's disease.